Prophylactic Scopolamine Butylbromide and Death Rattle in Patients at the End of Life - Reply

Harriette J. Van Esch*, Lia Van Zuylen, Carin C.D. Van Der Rijt

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)285-286
Number of pages2
JournalJAMA - Journal of the American Medical Association
Issue number3
Publication statusPublished - 18 Jan 2022

Bibliographical note

Funding Information:
Conflict of Interest Disclosures: Dr van Esch reported receiving grants from Laurens Zorg in Balans during the conduct of the study. Dr van Zuylen reported receiving grants from the Netherlands Organization for Health Research and Development (ZonMw). Dr van der Rijt reported receiving grants from the ZonMw and Stichting Voorzieningenfonds Calando and serving as a consultant to Kyowa Kirin and Ipsen Pharmaceutica BV.

Cite this